Although the connection between mitochondrial modulation and galectin-3 appears indirect, reducing inflammation and improving insulin sensitivity may ultimately result in lower galectin-3 levels, further supporting the therapeutic effects of metformin in PCOS. The gene discussed is LGALS3; the disease is polycystic ovary syndrome.